[1] |
DOREILLE A, AZZI F, LARIVIÈRE-BEAUDOIN S, et al. Acute kidney injury, microvascular rarefaction, and estimated glomerular filtration rate in kidney transplant recipients[J]. Clin J Am Soc Nephrol, 2021, 16(3): 415-426. DOI: 10.2215/CJN.07270520.
|
[2] |
JOURDE-CHICHE N, FAKHOURI F, DOU L, et al. Endothelium structure and function in kidney health and disease[J]. Nat Rev Nephrol, 2019, 15(2): 87-108. DOI: 10.1038/s41581-018-0098-z.
|
[3] |
DOREILLE A, DIEUDÉ M, CARDINAL H. The determinants, biomarkers, and consequences of microvascular injury in kidney transplant recipients[J]. Am J Physiol Renal Physiol, 2019, 316(1): F9-F19. DOI: 10.1152/ajprenal.00163.2018.
|
[4] |
GUVEN G, HILTY MP, INCE C. Microcirculation: physiology, pathophysiology, and clinical application[J]. Blood Purif, 2020, 49(1/2): 143-150. DOI: 10.1159/000503775.
|
[5] |
LIGRESTI G, NAGAO RJ, XUE J, et al. A novel three-dimensional human peritubular microvascular system[J]. J Am Soc Nephrol, 2016, 27(8): 2370-2381. DOI: 10.1681/ASN.2015070747.
|
[6] |
HERRNBERGER L, SEITZ R, KUESPERT S, et al. Lack of endothelial diaphragms in fenestrae and caveolae of mutant PLVAP-deficient mice[J]. Histochem Cell Biol, 2012, 138(5): 709-724. DOI: 10.1007/s00418-012-0987-3.
|
[7] |
DOGNÉ S, FLAMION B. Endothelial glycocalyx impairment in disease: focus on hyaluronan shedding[J]. Am J Pathol, 2020, 190(4): 768-780. DOI: 10.1016/j.ajpath.2019.11.016.
|
[8] |
LEMOS DR, MARSH G, HUANG A, et al. Maintenance of vascular integrity by pericytes is essential for normal kidney function[J]. Am J Physiol Renal Physiol, 2016, 311(6): F1230-F1242. DOI: 10.1152/ajprenal.00030.2016.
|
[9] |
KIDA Y. Peritubular capillary rarefaction: an underappreciated regulator of CKD progression[J]. Int J Mol Sci, 2020, 21(21): 8255. DOI: 10.3390/ijms21218255.
|
[10] |
BARTOSCH AMW, MATHEWS R, TARBELL JM. Endothelial glycocalyx-mediated nitric oxide production in response to selective AFM pulling[J]. Biophys J, 2017, 113(1): 101-108. DOI: 10.1016/j.bpj.2017.05.033.
|
[11] |
MA Y, YANG X, CHATTERJEE V, et al. Role of neutrophil extracellular traps and vesicles in regulating vascular endothelial permeability[J]. Front Immunol, 2019, 10: 1037. DOI: 10.3389/fimmu.2019.01037.
|
[12] |
MATHIS S, PUTZER G, SCHNEEBERGER S, et al. The endothelial glycocalyx and organ preservation-from physiology to possible clinical implications for solid organ transplantation[J]. Int J Mol Sci, 2021, 22(8): 4019. DOI: 10.3390/ijms22084019.
|
[13] |
QUAGLIA M, DELLEPIANE S, GUGLIELMETTI G, et al. Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft[J]. Front Immunol, 2020, 11: 74. DOI: 10.3389/fimmu.2020.00074.
|
[14] |
VIÑAS JL, BURGER D, ZIMPELMANN J, et al. Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury[J]. Kidney Int, 2016, 90(6): 1238-1250. DOI: 10.1016/j.kint.2016.07.015.
|
[15] |
LAN S, YANG B, MIGNEAULT F, et al. Caspase-3-dependent peritubular capillary dysfunction is pivotal for the transition from acute to chronic kidney disease after acute ischemia-reperfusion injury[J]. Am J Physiol Renal Physiol, 2021, 321(3): F335-F351. DOI: 10.1152/ajprenal.00690.2020.
|
[16] |
DUNI A, LIAKOPOULOS V, KOUTLAS V, et al. The endothelial glycocalyx as a target of ischemia and reperfusion injury in kidney transplantation-where have we gone so far?[J]. Int J Mol Sci, 2021, 22(4): 2157. DOI: 10.3390/ijms22042157.
|
[17] |
MARUYAMA Y, ARAKI M, KIDOKORO K, et al. Evaluation of neutrophil dynamics change by protective effect of tadalafil after renal ischemia/reperfusion using in vivo real-time imaging[J]. Transplantation, 2022, 106(2): 280-288. DOI: 10.1097/TP.0000000000003803.
|
[18] |
邹志锐, 满江位, 杨立. DAMP与NET在器官缺血-再灌注损伤中作用新进展[J]. 器官移植, 2021, 12(6): 761-766. DOI: 10.3969/j.issn.1674-7445.2021.06.018.ZOU ZR, MAN JW, YANG L. Recent progress on the roles of DAMP and NET in organ ischemia-reperfusion injury[J]. Organ Transplant, 2021, 12(6): 761-766. DOI: 10.3969/j.issn.1674-7445.2021.06.018.
|
[19] |
CHEN X, YU C, JING H, et al. COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment[J]. Am J Transl Res, 2020, 12(12): 7640-7656.
|
[20] |
郭晖. 移植肾T细胞介导的排斥反应的病理学[J]. 器官移植, 2021, 12(2): 134-142. DOI: 10.3969/j.issn.1674-7445.2021.02.003.GUO H. Pathology of T cell-mediated rejection in renal allograft[J]. Organ Transplant, 2021, 12(2): 134-142. DOI: 10.3969/j.issn.1674-7445.2021.02.003.
|
[21] |
HUGHES AD, LAKKIS FG, OBERBARNSCHEIDT MH. Four-dimensional imaging of T cells in kidney transplant rejection[J]. J Am Soc Nephrol, 2018, 29(6): 1596-1600. DOI: 10.1681/ASN.2017070800.
|
[22] |
YAZDANI S, CALLEMEYN J, GAZUT S, et al. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation[J]. Kidney Int, 2019, 95(1): 188-198. DOI: 10.1016/j.kint.2018.08.027.
|
[23] |
CALVANI J, TERADA M, LESAFFRE C, et al. In situ multiplex immunofluorescence analysis of the inflammatory burden in kidney allograft rejection: a new tool to characterize the alloimmune response[J]. Am J Transplant, 2020, 20(4): 942-953. DOI: 10.1111/ajt.15699.
|
[24] |
DE SOUSA MV, GONÇALEZ AC, DE LIMA ZOLLNER R, et al. Treatment of antibody-mediated rejection after kidney transplantation: immunological effects, clinical response, and histological findings[J]. Ann Transplant, 2020, 25: e925488. DOI: 10.12659/AOT.925488.
|
[25] |
LV R, ZHANG W, HAN F, et al. Capillary deposition of complement C4d and C3d in Chinese renal allograft biopsies[J]. Dis Markers, 2015: 397613. DOI: 10.1155/2015/397613.
|
[26] |
ZHANG R. Donor-specific antibodies in kidney transplant recipients[J]. Clin J Am Soc Nephrol, 2018, 13(1): 182-192. DOI: 10.2215/CJN.00700117.
|
[27] |
ZHANG X, REED EF. Effect of antibodies on endothelium[J]. Am J Transplant, 2009, 9(11): 2459-2465. DOI: 10.1111/j.1600-6143.2009.02819.x.
|
[28] |
LI X, SUN Q, ZHANG M, et al. Capillary dilation and rarefaction are correlated with intracapillary inflammation in antibody-mediated rejection[J]. J Immunol Res, 2014: 582902. DOI: 10.1155/2014/582902.
|
[29] |
XU-DUBOIS YC, PELTIER J, BROCHERIOU I, et al. Markers of endothelial-to-mesenchymal transition: evidence for antibody-endothelium interaction during antibody-mediated rejection in kidney recipients[J]. J Am Soc Nephrol, 2016, 27(1): 324-332. DOI: 10.1681/ASN.2014070679.
|
[30] |
LOUIS K, HERTIG A, TAUPIN JL, et al. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss[J]. Am J Transplant, 2019, 19(9): 2434-2445. DOI: 10.1111/ajt.15340.
|
[31] |
GWON MG, AN HJ, KIM JY, et al. Anti-fibrotic effects of synthetic TGF-β1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions[J]. FASEB J, 2020, 34(1): 333-349. DOI: 10.1096/fj.201901307RR.
|
[32] |
WANG M, XU H, LI Y, et al. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes[J]. Theranostics, 2020, 10(26): 12144-12157. DOI: 10.7150/thno.48562.
|
[33] |
CHEN YT, CHANG FC, WU CF, et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis[J]. Kidney Int, 2011, 80(11): 1170-1181. DOI: 10.1038/ki.2011.208.
|
[34] |
HU W, LI Z, LI H, et al. Bone marrow-derived mesenchymal stem cells transplantation attenuates renal fibrosis following acute kidney injury by repairing the peritubular capillaries[J]. Exp Cell Res, 2022, 411(1): 112983. DOI: 10.1016/j.yexcr.2021.112983.
|
[35] |
LOVISA S, FLETCHER-SANANIKONE E, SUGIMOTO H, et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis[J]. Sci Signal, 2020, 13(635): eaaz2597. DOI: 10.1126/scisignal.aaz2597.
|
[36] |
MARTÍNEZ-SALGADO C, SÁNCHEZ-JUANES F, LÓPEZ-HERNÁNDEZ FJ, et al. Endothelial activin receptor-like kinase 1 (ALK1) regulates myofibroblast emergence and peritubular capillary stability in the early stages of kidney fibrosis[J]. Front Pharmacol, 2022, 13: 843732. DOI: 10.3389/fphar.2022.843732.
|
[37] |
LEBLEU VS, TADURI G, O'CONNELL J, et al. Origin and function of myofibroblasts in kidney fibrosis[J]. Nat Med, 2013, 19(8): 1047-1053. DOI: 10.1038/nm.3218.
|
[38] |
BÁBÍČKOVÁ J, KLINKHAMMER BM, BUHL EM, et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries[J]. Kidney Int, 2017, 91(1): 70-85. DOI: 10.1016/j.kint.2016.07.038.
|
[39] |
HOHENSTEIN B, HUGO C. Peritubular capillaries: an important piece of the puzzle[J]. Kidney Int, 2017, 91(1): 9-11. DOI: 10.1016/j.kint.2016.08.033.
|
[40] |
WANG Y, ZUO B, WANG N, et al. Calcium dobesilate mediates renal interstitial fibrosis and delay renal peritubular capillary loss through Sirt1/p53 signaling pathway[J]. Biomed Pharmacother, 2020, 132: 110798. DOI: 10.1016/j.biopha.2020.110798.
|
[41] |
王雅楠, 徐涛, 王万鹏, 等. 表观遗传修饰在作物重要性状形成中的作用[J]. 遗传, 2021, 43(9): 858-879. DOI: 10.16288/j.yczz.21-170.WANG YN, XU T, WANG WP, et al. Role of epigenetic modifications in the development of crops essential traits[J]. Hereditas, 2021, 43(9): 858-879. DOI: 10.16288/j.yczz.21-170.
|
[42] |
荐思婧, 宁超, 高磊, 等. 表观遗传信息在动物中的跨代遗传和重编程[J]. 中国科学(生命科学), 2021, 51(5): 556-566. DOI: 10.1360/SSV-2019-0229.JIAN SJ, NING C, GAO L, et al. The transgenerational inheritance and reprogramming of epigenetic information in animals[J]. Sci Sin Vitae, 2021, 51(5): 556-566. DOI: 10.1360/SSV-2019-0229.
|
[43] |
ZHAO LY, SONG J, LIU Y, et al. Mapping the epigenetic modifications of DNA and RNA[J]. Protein Cell, 2020, 11(11): 792-808. DOI: 10.1007/s13238-020-00733-7.
|
[44] |
GUO C, DONG G, LIANG X, et al. Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications[J]. Nat Rev Nephrol, 2019, 15(4): 220-239. DOI: 10.1038/s41581-018-0103-6.
|
[45] |
XIANG X, ZHU J, DONG G, et al. Epigenetic regulation in kidney transplantation[J]. Front Immunol, 2022, 13: 861498. DOI: 10.3389/fimmu.2022.861498.
|